BIOMAT Database Logo BIOMAT Database Logo

Comparison of intravenous immunoglobulins for naturally occurring autoantibodies against amyloid-beta. 2010

Karthikeyan Balakrishnan, and Luminita-Cornelia Andrei-Selmer, and Thorsten Selmer, and Michael Bacher, and Richard Dodel
Department of Neurology, Philipps-University, Marburg, Germany.

Intravenous immunoglobulins (IVIG) are currently used for therapeutic purposes in autoimmune disorders. Recently, we demonstrated the presence of naturally occurring antibodies against amyloid-beta (nAbs-Abeta) within the pool of IVIG. In this study, we compared different brands of IVIG for nAbs-Abeta and have found differences in the specificity of the nAbs-Abeta towards Abeta(1-40) and Abeta(1-42). We analyzed the influence of a pH-shift over the course of antibody storage using ELISA and investigated antibody dimerization at acidic and neutral pH as well as differences in the IgG subclass distributions among the IVIG using both HPLC and a nephelometric assay. Furthermore, we investigated the epitope region of purified nAbs-Abeta. The differences found in Abeta specificity are not directly proportionate to the binding nature of these antibodies when administered in vivo. This information, however, may serve as a guide when choosing the commercial source of IVIG for therapeutic applications in Alzheimer's disease.

UI MeSH Term Description Entries
D009391 Nephelometry and Turbidimetry Chemical analysis based on the phenomenon whereby light, passing through a medium with dispersed particles of a different refractive index from that of the medium, is attenuated in intensity by scattering. In turbidimetry, the intensity of light transmitted through the medium, the unscattered light, is measured. In nephelometry, the intensity of the scattered light is measured, usually, but not necessarily, at right angles to the incident light beam. Turbidimetry,Nephelometry,Turbidimetry and Nephelometry
D010446 Peptide Fragments Partial proteins formed by partial hydrolysis of complete proteins or generated through PROTEIN ENGINEERING techniques. Peptide Fragment,Fragment, Peptide,Fragments, Peptide
D002850 Chromatography, Gel Chromatography on non-ionic gels without regard to the mechanism of solute discrimination. Chromatography, Exclusion,Chromatography, Gel Permeation,Chromatography, Molecular Sieve,Gel Filtration,Gel Filtration Chromatography,Chromatography, Size Exclusion,Exclusion Chromatography,Gel Chromatography,Gel Permeation Chromatography,Molecular Sieve Chromatography,Chromatography, Gel Filtration,Exclusion Chromatography, Size,Filtration Chromatography, Gel,Filtration, Gel,Sieve Chromatography, Molecular,Size Exclusion Chromatography
D003429 Cross Reactions Serological reactions in which an antiserum against one antigen reacts with a non-identical but closely related antigen. Cross Reaction,Reaction, Cross,Reactions, Cross
D004797 Enzyme-Linked Immunosorbent Assay An immunoassay utilizing an antibody labeled with an enzyme marker such as horseradish peroxidase. While either the enzyme or the antibody is bound to an immunosorbent substrate, they both retain their biologic activity; the change in enzyme activity as a result of the enzyme-antibody-antigen reaction is proportional to the concentration of the antigen and can be measured spectrophotometrically or with the naked eye. Many variations of the method have been developed. ELISA,Assay, Enzyme-Linked Immunosorbent,Assays, Enzyme-Linked Immunosorbent,Enzyme Linked Immunosorbent Assay,Enzyme-Linked Immunosorbent Assays,Immunosorbent Assay, Enzyme-Linked,Immunosorbent Assays, Enzyme-Linked
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000939 Epitopes Sites on an antigen that interact with specific antibodies. Antigenic Determinant,Antigenic Determinants,Antigenic Specificity,Epitope,Determinant, Antigenic,Determinants, Antigenic,Specificity, Antigenic
D001323 Autoantibodies Antibodies that react with self-antigens (AUTOANTIGENS) of the organism that produced them. Autoantibody
D001667 Binding, Competitive The interaction of two or more substrates or ligands with the same binding site. The displacement of one by the other is used in quantitative and selective affinity measurements. Competitive Binding
D016229 Amyloid beta-Peptides Peptides generated from AMYLOID BETA-PEPTIDES PRECURSOR. An amyloid fibrillar form of these peptides is the major component of amyloid plaques found in individuals with Alzheimer's disease and in aged individuals with trisomy 21 (DOWN SYNDROME). The peptide is found predominantly in the nervous system, but there have been reports of its presence in non-neural tissue. Alzheimer beta-Protein,Amyloid Protein A4,Amyloid beta-Peptide,Amyloid beta-Protein,beta Amyloid,beta-Amyloid Protein,Alzheimer's ABP,Alzheimer's Amyloid Fibril Protein,Amyloid AD-AP,Amyloid Fibril Protein, Alzheimer's,Amyloid beta-Proteins,ABP, Alzheimer's,AD-AP, Amyloid,Alzheimer ABP,Alzheimer beta Protein,Alzheimers ABP,Amyloid AD AP,Amyloid beta Peptide,Amyloid beta Peptides,Amyloid beta Protein,Amyloid beta Proteins,Amyloid, beta,Protein A4, Amyloid,Protein, beta-Amyloid,beta Amyloid Protein,beta-Peptide, Amyloid,beta-Peptides, Amyloid,beta-Protein, Alzheimer,beta-Protein, Amyloid,beta-Proteins, Amyloid

Related Publications

Karthikeyan Balakrishnan, and Luminita-Cornelia Andrei-Selmer, and Thorsten Selmer, and Michael Bacher, and Richard Dodel
Naturally occurring autoantibodies against β-Amyloid.
January 2012, Advances in experimental medicine and biology,
Karthikeyan Balakrishnan, and Luminita-Cornelia Andrei-Selmer, and Thorsten Selmer, and Michael Bacher, and Richard Dodel
Naturally occurring autoantibodies against hidden cellular antigens.
March 1975, Indian journal of experimental biology,
Karthikeyan Balakrishnan, and Luminita-Cornelia Andrei-Selmer, and Thorsten Selmer, and Michael Bacher, and Richard Dodel
Intravenous immunoglobulins containing antibodies against beta-amyloid for the treatment of Alzheimer's disease.
October 2004, Journal of neurology, neurosurgery, and psychiatry,
Karthikeyan Balakrishnan, and Luminita-Cornelia Andrei-Selmer, and Thorsten Selmer, and Michael Bacher, and Richard Dodel
Naturally occurring polyphenolic inhibitors of amyloid beta aggregation.
July 2014, Bioorganic & medicinal chemistry letters,
Karthikeyan Balakrishnan, and Luminita-Cornelia Andrei-Selmer, and Thorsten Selmer, and Michael Bacher, and Richard Dodel
Extending the functional characteristics of naturally occurring autoantibodies against β-Amyloid, Prion Protein and α-Synuclein.
January 2018, PloS one,
Karthikeyan Balakrishnan, and Luminita-Cornelia Andrei-Selmer, and Thorsten Selmer, and Michael Bacher, and Richard Dodel
Identification of naturally occurring spirostenols preventing beta-amyloid-induced neurotoxicity.
January 2004, Steroids,
Karthikeyan Balakrishnan, and Luminita-Cornelia Andrei-Selmer, and Thorsten Selmer, and Michael Bacher, and Richard Dodel
Naturally occurring autoantibodies to apoptotic cells.
January 2012, Advances in experimental medicine and biology,
Karthikeyan Balakrishnan, and Luminita-Cornelia Andrei-Selmer, and Thorsten Selmer, and Michael Bacher, and Richard Dodel
Naturally-occurring autoantibodies to mouse thymocytes.
June 1971, Israel journal of medical sciences,
Karthikeyan Balakrishnan, and Luminita-Cornelia Andrei-Selmer, and Thorsten Selmer, and Michael Bacher, and Richard Dodel
Comparison of naturally occurring poliovirus-reactive immunoglobulins in bovine and equine sera.
April 1987, Japanese journal of medical science & biology,
Karthikeyan Balakrishnan, and Luminita-Cornelia Andrei-Selmer, and Thorsten Selmer, and Michael Bacher, and Richard Dodel
Effect of Different Aβ Aggregates as Antigen on the Measure of Naturally Occurring Autoantibodies against Amyloid-β40/42 in IVIG.
January 2019, Current Alzheimer research,
Copied contents to your clipboard!